Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, consumer-oriented segment of its business, while also giving the diabetes unit more room to focus and compete in its own crowded market.
The post Why Is Medtronic Spinning Off Its Diabetes Business? appeared first on MedCity News.
